S152 Investigating the role of fluoroquinolones in the treatment of isoniazid resistant tuberculosis: implications for the 2018 WHO guidance
Sign Up to like & getrecommendations! Published in 2018 at "Thorax"
DOI: 10.1136/thorax-2018-212555.158
Abstract: 2018 World Health Organization (WHO) guidelines for isoniazid resistant (INH-R) tuberculosis recommend a treatment regimen of four drugs continuously for six months- rifampicin, pyrazinamide, ethambutol, and levofloxacin; with or without isoniazid ([H]RZE-Lfx)- once drug sensitivity… read more here.
Keywords: fluoroquinolones treatment; regimen specific; treatment; isoniazid resistant ... See more keywords